What is the IM@Home program studying for people with cancer?

The IM@Home program is being studied to see if a virtual mind-body and fitness approach can improve patient-reported outcomes, values, and experiences during cancer treatments. This study evaluates how such programs may help manage symptoms like fatigue and psychological distress. It is led by Memorial Sloan Kettering Cancer Center to support patients undergoing various cancer therapies.

Who may be eligible for this cancer clinical trial?

Adults aged 18 and older with diagnoses such as head and neck, thoracic, gynecologic, melanoma, breast, or ovarian cancer may be eligible. Participants should be receiving or have recently completed cancer treatment and report moderate to severe fatigue. The trial is open to English-speaking individuals with a certain functional level. Please review eligibility criteria for more details.

Is there any cost to participate in this cancer clinical trial?

Study-related care, including the program sessions and all trial visits, is provided at no cost. However, personal travel or internet expenses may vary and are usually not covered. Participants should consider their own costs for joining the study.

Actively Recruiting

Phase Not Applicable

Age: 18Years +

All Genders

ID05053230

Integrative Medicine at Home Program for Adults With Various Cancers Undergoing Treatment

Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-07-08

324

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are studying whether a virtual mind-body program called Integrative Medicine at Home IMHome can improve how people with various types of cancer feel and experience treatment. This research focuses on patients undergoing systemic cancer treatments such as chemotherapy, immunotherapy, radiotherapy, targeted therapies, or surgery. The goal is to assess patient-reported outcomes, values, and experiences during these treatments. Participants are randomly assigned to one of two groups. One group takes part in a 12-week virtual mind-body and fitness program via Zoom, choosing from weekly classes like yoga, dance therapy, tai chi, meditation, or music therapy led by specialized therapists. Each class lasts 30 to 45 minutes. The other group receives enhanced usual care, including a handout and access to on-demand meditation and relaxation recordings online. During the study, participants will be monitored for 12 weeks. Researchers will evaluate fatigue severity, symptom intensity, insomnia, psychological distress, pain, treatment expectations, satisfaction with the intervention, and healthcare usage such as treatment disruptions and unplanned medical visits. Attendance to the IMHome sessions will also be tracked. This comprehensive approach aims to understand how the program may affect patients well-being while undergoing cancer treatment.

CONDITIONS

Brief Title

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Who Can Participate

Age: 18Years +

All Genders

Eligibility Criteria

You may qualify if you...

Age 18 years or older
Karnofsky score of 60 or greater
Life expectancy greater than six months
English speaking
Diagnosis of head and neck, thoracic, gynecologic, melanoma, breast, or ovarian cancer
Actively receiving systemic oncological treatment or radiotherapy, or within 4 weeks of radiotherapy completion or primary cytoreductive surgery
Worst fatigue over the last 7 days rated 4 or greater on a 0-10 scale
For first remission gynecologic cancer: completed definitive first line treatment (maintenance hormonal or targeted therapies allowed)
For advanced cancer: diagnosis of specified advanced stages of lung, pancreatic, cholangiocarcinoma, liver, ampullary, gastrointestinal, ovarian, fallopian tube, breast, testicular, genitourinary, sarcoma, melanoma, endocrine, lymphoma, myeloma, or leukemia cancers and actively receiving treatment, radiotherapy, or under surveillance
For cancer survivors: completed active cancer treatment and worst fatigue over last 7 days rated 4 or greater

You will not qualify if you...

Cognitive impairment preventing response to assessments or requiring legally authorized representatives
Unwillingness to accept random assignment
Concurrent enrollment in competing integrative medicine trials with symptom or toxicity as primary outcome (other therapeutic protocols allowed)

Research Team

Karolina Bryl, PhD

Michael Postow, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here